Definium Therapeutics DFTX
$28.34 −$1.14 (-3.87%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.05 -1.02%
Open$29.14
Prev close$29.48
Day range$28.18 – $29.51
Volume3.24M
Market cap$3.88B
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±2.0%last 4 reports
Closed higher1 of 425% of the time
Best reaction+0.9%
Worst reaction-5.0%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 9 Nov 2026 | After Market | ±12.8% | -2.12% | Within range |
| 2026/Q2 | 6 Aug 2026 | After Market | ±23.4% | +0.00% | Within range |
| 2026/Q1 | 7 May 2026 | After Market | ±10.0% | -4.96% | Within range |
| 2025/Q4 | 26 Feb 2026 | After Market | ±12.3% | +0.93% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$72.28M-58.3% YoY
Net profit-$50.96M+24.2% YoY
Diluted EPS-$0.46+41.0% YoY
Free cash flow-$52.98M-79.2% YoY
Operating cash flow-$52.98M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Return on equity-61.4%
Return on assets-51.5%
Return on invested capital-60.1%
Current ratio15.53
Liabilities / assets9.9%
Cash & investments$1.05B
Total debt$36.66M
Net cash (debt)$1.01B
No comments yet — be the first to weigh in on DFTX.
Sign in to join the discussion.